Tazloc-Beta 50 Tablet

Tazloc-Beta 50 Tablet

Tazloc-Beta 50 Tablet is a high-potency pharmacological intervention containing a synergistic combination of Telmisartan (40mg) and Metoprolol Succinate (50mg), specifically engineered for the clinical management of hypertension and the reduction of cardiovascular morbidity. Utilizing a unique “Dual-Mechanism” delivery system, this medication works by concurrently inhibiting the Angiotensin II receptor and selectively blocking Beta-1 adrenergic receptors. The Telmisartan component facilitates systemic vasodilation and inhibits aldosterone secretion, while the sustained-release Metoprolol Succinate modulates the heart rate and reduces myocardial oxygen demand. This targeted biochemical action provides a decisive therapeutic response by stabilizing blood pressure fluctuations and protecting vital organs from the long-term effects of chronic hypertension.

Key Features

• Specifically formulated to target two distinct physiological pathways for superior blood pressure regulation.
• Clinically recognized for providing a steady plasma concentration of beta-blocker over 24 hours to prevent heart rate spikes.
• Specifically engineered with Telmisartan to reduce protein excretion and preserve kidney function in hypertensive patients.
• Acts as a functional catalyst to decrease the strain on the heart muscle, improving overall cardiac efficiency.
• Formulated to promote the relaxation of blood vessels, reducing systemic peripheral resistance and improving circulation.

Key Ingredients

• Telmisartan (40mg)
• Metoprolol Succinate (50mg)
• Microcrystalline Cellulose
• Povidone (K-30)
• Magnesium Stearate

Precautions

• Consult with a cardiologist or healthcare professional before use, especially if you have a history of asthma, heart block, or liver dysfunction.
• Strictly prohibited during pregnancy, as Telmisartan can cause serious injury or death to the developing fetus.
• Inform your surgeon or anesthesiologist that you are taking a beta-blocker, as it may interact with certain anesthetic agents.
• Do not stop taking this medication suddenly; abrupt withdrawal can lead to rebound hypertension or severe cardiac events.
• Use with caution if you have diabetes, as Metoprolol may mask the symptoms of hypoglycemia (low blood sugar), such as a rapid heart rate.
• This medication may cause localized dizziness or fatigue; avoid driving or operating heavy machinery until your individual response is determined.

How to Use

• Swallow the tablet whole with a full glass of water. Do not crush, chew, or break the tablet, as this interferes with the sustained-release mechanism.
• For optimal clinical results, take one Tazloc-Beta 50 tablet at the same time every day, preferably in the morning or as directed by your physician.
• Maintain a strict daily regimen to ensure continuous 24-hour protection of the cardiovascular system.
• This medication can be taken with or without food; however, consistency in administration relative to meals is recommended for stable absorption.
• If a dose is missed, take it as soon as possible, unless it is nearly time for the next dose. Do not double the dosage to compensate for a missed one.
• Keep the tablets in their original blister pack, stored in a cool, dry place (below 30°C) away from direct moisture and sunlight.

Legal Disclaimer: Tazloc-Beta 50 Tablet is a prescription-only medication. Individual results vary based on the baseline cardiovascular health and metabolic rate of the patient. This product is not intended for the immediate treatment of a hypertensive crisis. This information is for educational purposes and is not a substitute for professional medical consultation or a formal cardiac assessment.